3,4-Methylenedioxy-N-ethylamphetamine
3,4-Methylenedioxy-N-ethylamphetamine[edit]

3,4-Methylenedioxy-N-ethylamphetamine (MDEA) is a synthetic entactogen of the amphetamine class. It is chemically related to MDMA and MDA, and is known for its psychoactive effects. MDEA is commonly referred to as "Eve" in the context of recreational use.
Chemical Structure and Properties[edit]

MDEA is a member of the phenethylamine and amphetamine chemical classes. Its chemical structure consists of a methylenedioxy ring attached to the phenyl group, with an ethyl group attached to the nitrogen atom of the ethylamine chain. This structure is similar to that of MDMA, with the primary difference being the ethyl group in place of the methyl group.
Pharmacology[edit]
MDEA acts primarily as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). It increases the levels of these neurotransmitters in the brain, leading to its psychoactive effects. The entactogenic effects of MDEA are attributed to its action on the serotonin system, similar to other drugs in the MDxx family.
Effects[edit]
The effects of MDEA are similar to those of MDMA, though generally considered to be less intense. Users report feelings of euphoria, increased sociability, and enhanced sensory perception. The duration of effects typically lasts 3 to 6 hours, with a peak occurring around 1 to 2 hours after ingestion.
Synthesis[edit]

MDEA can be synthesized from safrole, a precursor also used in the synthesis of MDMA and MDA. The synthesis involves several chemical reactions, including the formation of the methylenedioxy ring and the attachment of the ethylamine chain.
Legal Status[edit]
MDEA is classified as a Schedule I controlled substance in many countries, including the United States, under the Controlled Substances Act. This classification indicates that it is considered to have a high potential for abuse and no accepted medical use.
Related Compounds[edit]
- MDMA (3,4-Methylenedioxy-N-methylamphetamine)
- MDA (3,4-Methylenedioxyamphetamine)
- MBDB (3,4-Methylenedioxy-N-methylbutanamine)
Related Pages[edit]
Gallery[edit]
-
Chemical structure of MDEA
-
3D model of MDEA
-
Synthesis pathway of MDA from safrole
-
Chemical structure of 3,4-Methylenedioxy-N-ethylamphetamine
-
3D van der Waals model of 3,4-Methylenedioxy-N-ethylamphetamine
-
Synthesis pathway of MDA from safrole
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian